How alcohol affects lung and liver health in people with HIV
Alcohol metabolism potentiates HIV-induced lung and liver multimorbidity via inter-organ crosstalk
This study is looking at how drinking alcohol might affect the health of people living with HIV, especially how it could make lung and liver problems worse, so we can find better ways to help manage their overall health.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11085643 on NIH RePORTER |
What this research studies
This research investigates the impact of alcohol consumption on the health of individuals living with HIV, particularly focusing on how alcohol may worsen lung and liver conditions. The study aims to understand the mechanisms by which alcohol metabolism influences the release of extracellular vesicles from the lungs, which may then affect liver function and contribute to chronic diseases. By examining the interplay between HIV, alcohol, and organ health, the research seeks to uncover new insights into managing multimorbidity in patients with HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who consume alcohol and may be experiencing or at risk for lung and liver complications.
Not a fit: Patients who do not have HIV or those who do not consume alcohol may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for managing lung and liver health in individuals with HIV, potentially reducing the burden of multimorbidity.
How similar studies have performed: Previous research has indicated that alcohol can exacerbate health issues in individuals with HIV, suggesting that this study builds on established findings rather than exploring a completely novel approach.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: New-Aaron, Moses O — Emory University
- Study coordinator: New-Aaron, Moses O
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.